MLM Medical Labs, a central and specialty lab services provider supporting clinical trials, biomarker testing, and drug development for life sciences and biopharma customers, has been sold by Great Point Partners to Labcorp. Headquartered in Mönchengladbach, Germany, MLM has over 30 years of experience and manages more than 300 clinical trials simultaneously. The company operates laboratories in Memphis, Tennessee, and Pretoria, South Africa, and offers central lab testing, biomarker testing, assay development, kit building, and long-term sample management and storage.

Under GPP’s ownership, MLM quadrupled its revenue and EBITDA, expanded its geographic footprint from a single German site to the US and South Africa, and strengthened its offerings while preserving its culture. Great Point Partners added two tuck-in acquisitions in the US and South Africa to broaden MLM’s global reach. William Blair advised MLM on the sale, with Mc Dermott Will & Schulte serving as legal counsel.

Founded in 2003 and based in Greenwich, Connecticut, GPP is a healthcare-focused investment firm with 30 professionals managing approximately $1.7 billion across its funds, having invested in over 100 health care companies.